Ladenburg Thalmann Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1.8M | Buy |
56,130
+1,469
| +3% | +$47.2K | 0.01% | 936 |
|
|
2019
Q3 | $1.35M | Buy |
54,661
+50,574
| +1,237% | +$1.25M | 0.01% | 1035 |
|
|
2019
Q2 | $1.28M | Sell |
4,087
-989
| -19% | -$310K | 0.01% | 1051 |
|
|
2019
Q1 | $2.09M | Buy |
5,076
+121
| +2% | +$49.9K | 0.02% | 749 |
|
|
2018
Q4 | $1.85M | Buy |
4,955
+126
| +3% | +$47.1K | 0.02% | 703 |
|
|
2018
Q3 | $1.95M | Buy |
4,829
+961
| +25% | +$388K | 0.02% | 740 |
|
|
2018
Q2 | $1.33M | Hold |
3,868
| – | – | 0.01% | 899 |
|
|
2018
Q1 | $1.33M | Buy |
3,868
+189
| +5% | +$65K | 0.01% | 899 |
|
|
2017
Q4 | $1.38M | Sell |
3,679
-10
| -0.3% | -$3.76K | 0.01% | 874 |
|
|
2017
Q3 | $1.65M | Sell |
3,689
-782
| -17% | -$350K | 0.02% | 722 |
|
|
2017
Q2 | $2.2M | Buy |
4,471
+281
| +7% | +$138K | 0.03% | 552 |
|
|
2017
Q1 | $1.62M | Buy |
4,190
+221
| +6% | +$85.6K | 0.02% | 658 |
|
|
2016
Q4 | $1.46M | Buy |
3,969
+575
| +17% | +$211K | 0.02% | 654 |
|
|
2016
Q3 | $1.36M | Buy |
3,394
+529
| +18% | +$212K | 0.02% | 639 |
|
|
2016
Q2 | $1M | Buy |
2,865
+307
| +12% | +$107K | 0.02% | 755 |
|
|
2016
Q1 | $946K | Sell |
2,558
-296
| -10% | -$109K | 0.02% | 730 |
|
|
2015
Q4 | $1.55M | Sell |
2,854
-523
| -15% | -$284K | 0.03% | 492 |
|
|
2015
Q3 | $1.57M | Buy |
3,377
+135
| +4% | +$62.6K | 0.03% | 460 |
|
|
2015
Q2 | $1.65M | Sell |
3,242
-51
| -2% | -$26K | 0.03% | 485 |
|
|
2015
Q1 | $1.49M | Buy |
3,293
+875
| +36% | +$395K | 0.03% | 514 |
|
|
2014
Q4 | $992K | Buy |
2,418
+319
| +15% | +$131K | 0.02% | 604 |
|
|
2014
Q3 | $757K | Buy |
2,099
+109
| +5% | +$39.3K | 0.02% | 618 |
|
|
2014
Q2 | $562K | Sell |
1,990
-1,697
| -46% | -$479K | 0.02% | 731 |
|
|
2014
Q1 | $1.11M | Buy |
3,687
+198
| +6% | +$59.4K | 0.03% | 425 |
|
|
2013
Q4 | $960K | Buy |
3,489
+1,890
| +118% | +$520K | 0.03% | 454 |
|
|
2013
Q3 | $500K | Buy |
1,599
+168
| +12% | +$52.5K | 0.02% | 663 |
|
|
2013
Q2 | $322K | Buy |
+1,431
| New | +$322K | 0.01% | 788 |
|